Isolere Bio

Isolere Bio is an innovator in biopharmaceutical purification technologies, specializing in streamlined solutions for complex biologics. The company works diligently to enhance the efficiency, purity, and cost-effectiveness of biopharmaceutical processes by leveraging cutting-edge materials into next generation solutions. Each product is designed with scalability and sustainability in mind to enable customers to rapidly and reliably commercialize life-saving therapies.

Incorporated in 2017, Isolere Bio became part of Donaldson Company (NYSE: DCI) in early 2023.

For more information, visit isolerebio.com